Teena Thacker

India: Sun Pharmaceutical acquires Japanese drugmaker Pola for $1m

The acquisition is in line with Sun Pharma’s strategy to strengthen its global dermatology presence.

Fortis Healthcare CEO Bhavdeep Singh quits ahead of board makeover

The Fortis board is expected to meet next week to appoint representatives from Malaysia’s IHH Healthcare.

India: Competition watchdog CCI may approve Fortis-IHH deal by October-end

Following the CCI approval, IHH could pick up a controlling stake in Fortis by infusing around Rs4,000 crore for equity shares at Rs170 apiece.

India: IHH Healthcare, TPG-Manipal submit fresh bids for Fortis acquisition

TPG-Manipal, which had earlier agreed to pay Rs 180 per share, may have lowered its bid.

India: Bidding war for Fortis intensifies as Malaysia’s IHH, Munjal-Burmans revise offer

Malaysia’s IHH Healthcare Bhd. on Tuesday revised its offer to Rs175 per share from its earlier offer Rs160 per share, which it made on 24 April.

Ranjan Pai tops India’s most successful entrepreneurs list with Fortis-Manipal deal

On Tuesday, the board of Manipal Education approved the merger of its hospital assets with that of Fortis Healthcare.

India: CCI pall over Bayer-Monsanto deal may hinder the process globally

Among countries that have cleared the deal are South Africa, Russia and Ukraine.

Merck’s India unit part of German parent’s global sale plans

The German drug maker is preparing for “strategic options” for its consumer health business globally, including a potential full or partial sale of business.